SHPH — Shuttle Pharmaceuticals Holdings, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1757499 ·
Last close
$4.11
Market Cap
$2.40M
52W High
$55.90
52W Low
$2.58
ADV30
48,067
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -2,216,822 | -2,152,471 | 11,809,327 | 1,089,946 | 8,463,084 |
| Dec 2025 | 0 | — | -2,788,235 | -2,614,895 | 10,475,977 | 334,005 | 8,221,531 |
| Sep 2025 | 0 | — | -2,266,942 | -2,347,302 | 3,542,927 | 2,094,643 | 2,148,766 |
| Jun 2025 | 0 | — | -3,910,406 | -3,706,465 | 5,504,429 | 4,817,672 | 1,898,910 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-9,372,030
Investing CF
$-3,092,722
Financing CF
$9,042,091
CapEx
$-36,000
Dividends Paid
$0
Buybacks
—
EPS Diluted TTM
$-123.70
As of
2026-09-27
Balance + Analyst (yfinance extras)
Retained Earnings
$-48,452,241
Inventory
—
Receivables
$0
ST Investments
$0
EBIT TTM
$-10,750,113
Pretax Income TTM
$-10,821,133
Interest Exp TTM
$71,020
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -11,916,824 | -11,721,669 | 10,475,977 | 8,221,531 | 2,254,446 | -9,481,645 |
| Dec 2024 | 0 | -7,696,170 | -9,144,797 | 2,506,290 | 1,797,138 | 709,152 | -7,327,230 |
| Dec 2023 | 0 | -5,892,382 | -6,592,723 | 5,951,736 | 1,895,965 | 4,055,771 | -5,581,147 |
| Dec 2022 | 0 | -2,343,826 | -4,996,069 | 8,653,545 | 975,676 | 7,677,869 | -2,666,411 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| VBIO | Valion Bio, Inc. | $2.40M | $2.70 | — |
| BIXT | BIOXYTRAN, INC | $2.42M | $0.02 | — |
| PPBT | PURPLE BIOTECH LTD. | $2.42M | $1.49 | — |
| ARTL | ARTELO BIOSCIENCES, INC. | $2.36M | $4.30 | — |
| GNPX | Genprex, Inc. | $2.30M | $2.81 | — |
News headlines (Yahoo Finance, 1h cache)
Shuttle Pharmaceuticals Holdings, Inc. Announces Receipt of NASDAQ Noncompliance Letter
2026-08-28 20:05 · Yahoo
Shuttle to Acquire United Dogecoin in Push to Build Public DOGE Mining Platform
2026-05-01 14:37 · Yahoo
SHPH, ILLR, IVF: Why These Stocks Posted Double-Digit Gains After-Hours Today
2026-06-26 01:33 · Yahoo
RETRANSMISSION: Shuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific Workflows
2026-03-27 12:00 · Yahoo
Shuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific Workflows
2026-03-26 20:05 · Yahoo
E.F. Hutton & Co. Serves as Exclusive Placement Agent on Shuttle Pharmaceuticals’ $3.5 Million Public Offering
2026-03-12 12:30 · Yahoo
Shuttle Pharmaceuticals Announces $3.5 Million Public Offering
2026-03-06 13:00 · Yahoo
Utah Approves AI Prescriptions Drugs. How AI Is Saving Time, Cutting Costs - and Why Molecule.ai's Drug Discovery Platform Matters More Than Ever
2026-01-13 21:00 · Yahoo
Shuttle Pharmaceuticals Acquires AI Health Platform
2025-11-21 14:30 · Yahoo
Shuttle Pharmaceuticals Announces Above-the-Market $2.5 Million Private Placement at Effective Price per Share of $4.00
2025-11-03 12:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.